Cite
Oncological, cognitive, and employment outcomes in a series of patients with IDH-mutated glioma resected following neoadjuvant chemotherapy.
MLA
Bursi, Marco, et al. “Oncological, Cognitive, and Employment Outcomes in a Series of Patients with IDH-Mutated Glioma Resected Following Neoadjuvant Chemotherapy.” Acta Neurochirurgica, vol. 165, no. 9, Sept. 2023, pp. 2461–71. EBSCOhost, https://doi.org/10.1007/s00701-023-05711-6.
APA
Bursi, M., Rizzo, C., Barberis, M., Poisson, I., Lehman-Che, J., Adle-Biassette, H., Froelich, S., & Mandonnet, E. (2023). Oncological, cognitive, and employment outcomes in a series of patients with IDH-mutated glioma resected following neoadjuvant chemotherapy. Acta Neurochirurgica, 165(9), 2461–2471. https://doi.org/10.1007/s00701-023-05711-6
Chicago
Bursi, Marco, Claudia Rizzo, Marion Barberis, Isabelle Poisson, Jacqueline Lehman-Che, Homa Adle-Biassette, Sébastien Froelich, and Emmanuel Mandonnet. 2023. “Oncological, Cognitive, and Employment Outcomes in a Series of Patients with IDH-Mutated Glioma Resected Following Neoadjuvant Chemotherapy.” Acta Neurochirurgica 165 (9): 2461–71. doi:10.1007/s00701-023-05711-6.